1. HSV-1 clinical isolates with unique in vivo and in vitro phenotypes and insight into genomic differences

   • Robert J. Danaher
   • Derrick E. Fouts
   • Craig S. Miller

   OriginalPaper 13 October 2016 Pages: 171 - 185

   

2. Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters

   • Katherine Zukor
   • Hong Wang
   • John D. Morrey

   OriginalPaper Open access 19 October 2016 Pages: 186 - 204

   

3. Pseudo-typed Semliki Forest virus delivers EGFP into neurons

   • Fan Jia
   • Huan Miao
   • Fuqiang Xu

   OriginalPaper 13 October 2016 Pages: 205 - 215

   

4. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication

   • Matteo Vassallo
   • R. Fabre
   • C. Pradier

   OriginalPaper 04 November 2016 Pages: 216 - 225

   

5. JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab

   • Elena Uleri
   • Gabriele Ibba
   • Antonina Dolei

   OriginalPaper 03 November 2016 Pages: 226 - 238

   

6. Association of midlife smoking status with change in processing speed and mental flexibility among HIV-seropositive and HIV-seronegative older men: the Multicenter AIDS Cohort Study

   • Wajiha Z. Akhtar-Khaleel
   • Robert L. Cook
   • Michael Plankey

   OriginalPaper 26 November 2016 Pages: 239 - 249

7. Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions

   • Khutso M. Mothapo
   • J. ten Oever
   • A. J. van der Ven

   OriginalPaper 23 November 2016 Pages: 250 - 259

   

8. Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin

   • Theodore R. Miller
   • Jeffrey J. Weiss
   • Monica Rivera-Mindt

   OriginalPaper 28 November 2016 Pages: 260 - 272

   

9. Cognitive function in early HIV infection

   • Aanchal Prakash
   • Jue Hou
   • Ann B. Ragin

   OriginalPaper 28 November 2016 Pages: 273 - 282

10. Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals

    • Josué Pérez-Santiago
    • Michelli F. De Oliveira
    • Sanjay R. Mehta

    OriginalPaper 05 December 2016 Pages: 283 - 289

    

11. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration

    • Jerel A. Fields
    • Jeff Metcalf
    • Eliezer Masliah

    OriginalPaper 19 January 2017 Pages: 290 - 303

    

12. Vocal emotion processing deficits in HIV-infected individuals

    • A. González-Baeza
    • J. R. Arribas
    • F. Carvajal

    OriginalPaper 09 December 2016 Pages: 304 - 312

    

13. Reaction of complement factors and proteasomes in experimental encephalitis

    • Stefan Lange
    • Tomas Bergström
    • Ivar Lönnroth

    OriginalPaper Open access 02 December 2016 Pages: 313 - 318

    

14. Neuroimaging abnormalities in clade C HIV are independent of Tat genetic diversity

    • Robert H. Paul
    • Sarah Phillips
    • John Joska

    OriginalPaper 02 December 2016 Pages: 319 - 328

    

15. Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome

    • Diana Ferraro
    • Veronica Galli
    • Patrizia Sola

    Short Communication 22 November 2016 Pages: 329 - 334

    

16. Acyclovir resistance in herpes simplex virus type I encephalitis: a case report

    • M. Bergmann
    • R. Beer
    • E. Schmutzhard

    Case Report Open access 27 October 2016 Pages: 335 - 337